The drug, Telomelysin, contains a genetically modified virus that replicates only in tumour cells and destroys them without harming healthy cells.
In trials combining the treatment with radiotherapy, the tumour disappeared after 18 months in around half of the 36 patients. The cost of the course of treatment is approximately $58,500.
